Phase II study of repetitive mini-transplant using a novel dose-intense salvage chemotherapy regimen (M-DHAP) followed by high dose therapy (HDT) and autologous stem cell transplant (ASCT) in relapsed aggressive non-Hodgkin lymphoma (NHL). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Bordeleau, Louise
  • Mangel, J
  • Imrie, KR
  • Buckstein, R
  • Spaner, D
  • Reis, M
  • Sawka, C
  • Hewitt, K
  • Pavlin, P
  • Berinstein, NL

publication date

  • November 16, 2001

published in